QT Imaging Holdings

QTI

時価総額 $3513万

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its U.S. distribution partner, NXC Imaging, Inc., a wholly owned subsidiary of Canon Medical Systems USA, Inc., has entered into a national group purchasing agreement with Premier, Inc. covering the QTI Breast Acoustic CT™ scanner and provid.

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that CPT® Category III code 1079T for 3D quantitative transmission water bath volumetric ultrasound tomography of the breast is effective for dates of service beginning October 1, 2026. The code is effective for use three months earlier than the.

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that Chief Executive Officer Dr. Raluca Dinu will ring the Nasdaq Stock Market Closing Bell on October 2, 2026, in recognition of Breast Cancer Awareness Month. She will be joined by QT Imaging's executive leadership, team members, and key partne.

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced it will be honored during Premier's annual Supplier Innovation Celebration at its 2026 Breakthroughs Conference and Exhibition, taking place October 6-8, 2026. The Innovation Celebration recognizes groundbreaking healthcare technologies launched.

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced the appointment of Mark L. Winkler, M.D., as Chief Medical Officer (CMO). “Mark has the perspective of an accomplished radiologist along with the experience of an entrepreneur who has built and scaled a very successful imaging organization,” said.

QT Imaging Holdings, Inc. (QTI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced its participation in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026, taking place September 15–16, 2026. Chief Financial Officer Jay Jennings will deliver a company presentation at 3:30 pm ET on September 15, followed by one.

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today issued a mid-year 2026 letter to shareholders from its CEO, Dr. Raluca Dinu. The full text of the letter appears below and at this link which can be found on the QT Imaging website. Dear Fellow Shareholders, I am energized by QT Imaging's many accomplishme.

QT Imaging Holdings, Inc. (QTI) Q2 2026 Earnings Call Transcript

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holding, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three and six months ended June 30, 2026, and provided a business update. “Our second quarter results demonstrate continued execution and the growing commercial momentum of QT Imaging. Revenue more than doubled year-over-y.